These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33213160)

  • 1. Hepatocellular carcinoma from the view of a transplant surgeon.
    Matěj K; Pavel T; Jiří F
    Klin Onkol; 2020; 33(Supplementum 3):13-19. PubMed ID: 33213160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative therapies for hepatocellular carcinoma: an update and perspectives.
    Sacco R; Antonucci M; Bresci G; Corti A; Giacomelli L; Mismas V; Rainieri M; Romano A; Eggenhoffner R; Tumino E; Cabibbo G
    Expert Rev Anticancer Ther; 2016; 16(2):169-75. PubMed ID: 26588992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.
    Muaddi H; Al-Adra DP; Beecroft R; Ghanekar A; Moulton CA; Doyle A; Selzner M; Wei A; McGilvray ID; Gallinger S; Grant DR; Cattral MS; Greig PD; Kachura J; Cleary SP; Sapisochin G
    Ann Surg Oncol; 2018 Apr; 25(4):991-999. PubMed ID: 29327179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma.
    Berumen J; Hemming A
    Abdom Radiol (NY); 2018 Jan; 43(1):185-192. PubMed ID: 28634617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
    Na GH; Kim EY; Hong TH; You YK; Kim DG
    HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How far can we go with hepatocellular carcinoma in living donor liver transplantation?
    Limkemann AJP; Abreu P; Sapisochin G
    Curr Opin Organ Transplant; 2019 Oct; 24(5):644-650. PubMed ID: 31397731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism and current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation].
    Wang HQ; Li L; Yang JY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):93-97. PubMed ID: 29804373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source.
    Sung PS; Yang H; Na GH; Hwang S; Kang D; Jang JW; Bae SH; Choi JY; Kim DG; Yoon SK; You YK
    Ann Transplant; 2017 May; 22():276-284. PubMed ID: 28473688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver transplant indication and waiting list inclusion].
    Husová L
    Vnitr Lek; 2013 Aug; 59(8):658-62. PubMed ID: 24007218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
    Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
    Cardiovasc Intervent Radiol; 2017 Mar; 40(3):410-420. PubMed ID: 27900445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single HCC between 2 and 5 cm: the grey zone: surgeon's perspective.
    Hasegawa K; Kokudo N; Sano K; Makuuchi M
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):430-3. PubMed ID: 19890599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for hepatocellular carcinoma: is surgeon a prognostic factor?
    Sharma R
    Indian J Gastroenterol; 2009; 28(2):78; author reply 78-9. PubMed ID: 19696998
    [No Abstract]   [Full Text] [Related]  

  • 20. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center.
    Grigorie R; Alexandrescu S; Smira G; Ionescu M; Hrehoreţ D; Braşoveanu V; Dima S; Ciurea S; Boeţi P; Dudus I; Picu N; Zamfir R; David L; Botea F; Gheorghe L; Tomescu D; Lupescu I; Boroş M; Grasu M; Dumitru R; Toma M; Croitoru A; Herlea V; Pechianu C; Năstase A; Popescu I
    Chirurgia (Bucur); 2017; 112(3):289-300. PubMed ID: 28675364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.